Abstract
The clinical use of platinum(II)-based drugs has serious side effects due to the non-specific reactions with both malignant and normal cells. To circumvent such major drawback, novel metallodrugs might be combined with suitable carrier molecules, as antibodies, to ensure selective attacks on tumours while sparing healthy tissues. In this contribution, we investigate the stability of a novel oxaliplatin derivate drug embedded in Herceptin (trastuzumab), an antibody which is able to recognise breast cancer cells, by using a wide panel of theoretical tools: docking, molecular dynamics and quantum calculations. Our calculations reveal the binding mechanism: the drug initially interacts non-covalently with the Pro40A and Asp167A residues, and the nitrogen of His171B subsequently replaces one of the water molecules coordinated to the platinum center, where the latter step reversibly fixes the drug into the antibody. These data might be used to further rationalise the synthesis of improved drugs beyond classical platinum(II) derivatives by improving the ligand-protein coupling mode.
Similar content being viewed by others
References
Rosenberg B, VanCamp L, Krigas T (1965). Nature 205:698–699
Kelland L (2007) Nat Rev Cancer 7:573–584
Jamieson E R, Lippard S J (1999) Chem Rev 99:2467–2498
McWhinney S R, Goldberg R M, McLeod H L (2009) Mol Cancer Ther 8:10–16
Jung Y, Lippard S J (2007) Chem Rev 107:1387–1407
Zimmermann T, Chval Z, Burda J V (2009) J Phys Chem B 113:3139–3150
Takahara P M, Frederick C A, Lippard S J (1996) J Am Chem Soc 118:12309–12321
Cepeda V, Fuertes M A, Castilla J, Alonso C, Quevedo C, Pérez J M (2007) Anticancer Ag Med Chemother 7:3–18
Pérez R P (1998) Eur J Cancer 34:1535–1544
Reedijk J (1999) Chem Rev 99:2499–2510
Burda J V, Leszczyński J (2003) Inorg Chem 42:7162–7172
Fuertes M A, Alonso C, Pérez J M (2003) Chem Rev 103:645–662
Wong E, Giandomenico C M (1999) Chem Rev 99:2351–2466
Lovejoy KS, Lippard SJ (2009) Dalton Trans 10651–10659
Samper K G, Vicente C, Rodriguez V, Atrian S, Cutillas N, Capdevila M, Ruiz J, Palacios O (2012) Dalton Trans 41:300–306
Sanchez-Cano C, Hannon MJ (2009) Dalton Trans 10702–10711
Ruíz J, Vicente C, de Haro C, Espinosa A (2011) Inorg Chem 50:2151–2158
Zamora A, Rodríguez V, Cutillas N, Yellol G S, Espinosa A, Samper K G, Capdevila M, Palacios O, Ruíz J (2013) J Inorg Biochem 128:48–56
Trail P, Willner D, Lasch S, Henderson A, Hofstead S, Casazza A, Firestone R, Hellstrom I, Hellstrom K (1993) Science 261:212–215
Butler JS, Sadler PJ (2013) Curr Opin Chem Biol 17:175–188
Cho H S, Mason K, Ramyar K X, Stanley A M, Gabelli S B, Denney D W Jr, Leahy D J (2003) Nature 421:756– 760
Hudis CA (2007) N Engl J Med 357:39–51. PMID: 17611206
Xu C, Wang B, Sun S (2009) J Am Chem Soc 131:4216–4217
Gao J, Liu Y G, Liu R, Zingaro R (2008) ChemMedChem 3:954–962
Zhao Y, Truhlar D G (2008) Acc Chem Res 41:157–167
Zhao Y, Truhlar D G (2008) Theor Chem Acc 120:215–241
Zhao Y, Truhlar D G (2011) Chem Phys Lett 502:1–13
Singh U C, Kollman P A (1984) J Comput Chem 5:129–145
Besler B H, Merz K M, Kollman P A (1990) J Comput Chem 11:431–439
Frisch M J, Trucks G W, Schlegel H B, Scuseria G E, Robb M A, Cheeseman J R, Scalmani G, Barone V, Mennucci B, Petersson G A, Nakatsuji H, Caricato M, Li X, Hratchian H P, Izmaylov A F, Bloino J, Zheng G, Sonnenberg J L, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery J A, Peralta J E, Ogliaro F, Bearpark M, Heyd J J, Brothers E, Kudin K N, Staroverov V N, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant J C, Iyengar S S, Tomasi J, Cossi M, Rega N, Millam J M, Klene M, Knox J E, Cross J B, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann R E, Yazyev O, Austin A J, Cammi R, Pomelli C, Ochterski J W, Martin R L, Morokuma K, Zakrzewski V G, Voth G A, Salvador P, Dannenberg J J, Dapprich S, Daniels A D, Farkas Ö, Foresman J B, Ortiz J V, Cioslowski J, Fox D J (2009) Gaussian 09, Revision D.01. Gaussian Inc., Wallingford
Scollard D A, Chan C, Holloway C M, Reilly R M (2011) Nucl Med Biol 38:129–136
Hermanto S, Haryuni R D, Ramli M, Mutalib A, Hudiyono S (2012) J Pharm 2:12–18
Stroganov O V, Novikov F N, Stroylov V S, Kulkov V, Chilov G G (2008) J Chem Inf Model 48:2371–2385
Navarro-Fernandez J, Pérez-Sánchez H, Martinez-Martinez I, Meliciani I, Guerrero J A, Vicente V, Corral J, Wenzel W (2012) J Med Chem 55:6403–6412
Vilar Sb, Cozza Gb, Moro Sb (2008) Curr Top Med Chem 8:1555–1572
Wang J, Cieplak P, Kollman P A (2000) J Comput Chem 21:1049–1074
Sánchez-Linares I, Pérez-Sánchez H, Cecilia J, Garcia J (2012) BMC Bioinf 13:S13
Contreras-García J, Johnson E R, Keinan S, Chaudret R, Piquemal J P, Beratan D N, Yang W (2011) J Chem Theory Comput 7:625–632
Johnson E R, Keinan S, Mori-Sánchez P, Contreras-García J, Cohen A J, Yang W (2010) J Am Chem Soc 132:6498– 6506
Contreras-García J, Yang W, Johnson E R (2011) J Phys Chem A 115:12983–12990
Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts M R, Smith J C, Kasson P M, van der Spoel D, Hess B, Lindahl E (2013) Bioinf 29:845–854
Wang J, Wolf R M, Caldwell J W, Kollman P A, Case D A (2004) J Comput Chem 25:1157–1174
Yao S, Plastaras J P, Marzilli L G (1994) Inorg Chem 33:6061–6077
Jorgensen W L, Chandrasekhar J, Madura J D, Impey R W, Klein M L (1983) J Chem Phys 79:926–935
Hess B, Bekker H, Berendsen H J C, Fraaije J G E M (1997) J Comput Chem 18:1463–1472
Berendsen H J C, Postma J P M, van Gunsteren W F, DiNola A, Haak J R (1984) J Chem Phys 81:3684–3690
Nosé S (1984) Mol Phys 52:255–268
Hoover W G (1985) Phys Rev A 31:1695–1697
Tomasi J, Mennucci B, Cammi R (2005) Chem Rev 105:2999–3093
Lau J K C, Ensing B (2010) Phys Chem Chem Phys 12:10348–10355
Ruiz J, Rodríguez V, Cutillas N, Espinosa A, Hannon MJ (2011) J Inorg Biochem 105:525–531
Cutillas N, Yellol G S, de Haro C, Vicente C, Rodríguez V, Ruíz J (2013) Coord Chem Rev 257:2784–2797
Dupont C, Patel C, Dumont E (2011) J Phys Chem B 115:15138–15144
Futera Z, Platts J A, Burda J V (2012) J Comput Chem 33:2092–2101
Loos P F, Dumont E, Laurent A D, Assfeld X (2009) Chem Phys Lett 475:120–123
Garrec J, Patel C, Rothlisberger U, Dumont E (2012) J Am Chem Soc 134:2111–2119
Acknowledgments
J. P. C.-C. acknowledges the support from the FP7 EU Marie Curie Actions through the Campus Mare Nostrum 37/38 CMN UMU Incoming Mobility Programme ACTion (U-IMPACT). J.C. acknowledges a FPU fellowship provided by the Ministerio de Educación of Spain. This work was partially supported by the Spanish Ministerio de Ciencia e Innovación under Projects CTQ2011-25872 and CONSOLIDER CSD2009-00038, by the Fundación Séneca del Centro de Coordinación de la Investigación de la Región de Murcia under Projects 08735/PI/08 and 18946/JLI/13. This work has been funded by the Nils Coordinated Mobility under grant 012-ABEL-CM-2014A, in part financed by the European Regional Development Fund (ERDF). This work was partially supported by the computing facilities of Extremadura Research Centre for Advanced Technologies (CETA −CIEMAT), funded by the European Regional Development Fund (ERDF). CETA −CIEMAT belongs to CIEMAT and the Government of Spain. The authors also thankfully acknowledge the computer resources and the technical support provided by the Plataforma Andaluza de Bioinformática of the University of Málaga. The authors acknowledge that the results of this research have been also achieved through the PRACE-2IP project (FP7 RI-283493) using the resources provided by the IBM PLX-GPU and based in Italy at CINECA.
Author information
Authors and Affiliations
Corresponding authors
Additional information
This paper belongs to Topical Collection MIB 2013 (Modeling Interactions in Biomolecules VI)
Rights and permissions
About this article
Cite this article
Cerón-Carrasco, J.P., Cerezo, J., Requena, A. et al. Labelling Herceptin with a novel oxaliplatin derivative: a computational approach towards the selective drug delivery. J Mol Model 20, 2401 (2014). https://doi.org/10.1007/s00894-014-2401-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00894-014-2401-7